Wordt geladen...
ACS Chemical Neuroscience Molecule Spotlight on Sabril
[Image: see text] Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Chemical Society
2010
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368665/ https://ncbi.nlm.nih.gov/pubmed/22778839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100025k |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|